Status:

COMPLETED

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study

Lead Sponsor:

The George Institute

Collaborating Sponsors:

Servier

Conditions:

Diabetes Mellitus, Type 2

Eligibility:

All Genders

Brief Summary

The study is designed to determine the long term, post trial effects of the two interventions studied in ADVANCE (routine blood pressure lowering with perindopril-indapamide as compared with placebo a...

Detailed Description

The long term, post randomization effects of the two study interventions will be investigated separately as they were for the main trial. This study will clarify and quantify the long-term, post trial...

Eligibility Criteria

Inclusion

  • Participated in ADVANCE
  • Ability to provide informed consent

Exclusion

  • None

Key Trial Info

Start Date :

January 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 1 2014

Estimated Enrollment :

8494 Patients enrolled

Trial Details

Trial ID

NCT00949286

Start Date

January 1 2010

End Date

February 1 2014

Last Update

May 19 2014

Active Locations (172)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 43 (172 locations)

1

LCC 80 - Canberra Hospital

Garran, Australian Capital Territory, Australia

2

LCC 28 - Royal Prince Alfred Hospital

Camperdown, New South Wales, Australia

3

LCC 48 - Gosford

Gosford, New South Wales, Australia

4

LCC 59 - Liverpool Hospital

Liverpool, New South Wales, Australia

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study | DecenTrialz